Signati Medical

Signati Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Signati Medical is a pre-revenue, private medical device startup focused on the male contraception market. Its lead product is the Sealed Vasectomy Procedure (SVP), a bipolar electrosurgical device and technique aimed at making vasectomies faster for physicians and more comfortable for patients, with the goal of enabling in-office procedures and easier recovery. The company has assembled a strong Clinical Advisory Board of prominent urologists and andrologists but has not yet launched commercially, indicating it is in a late-stage development or pre-launch phase. Signati operates in a large, established market with limited recent innovation, presenting a significant opportunity if it can successfully demonstrate clinical and commercial advantages over existing techniques.

Men's HealthContraception

Technology Platform

Bipolar electrosurgical platform for sealing the vas deferens during vasectomy, designed for speed, patient comfort, and in-office use.

Opportunities

The vasectomy device market is large and has seen little innovation, creating an opening for a differentiated product.
Signati's focus on an in-office, faster procedure with easier recovery targets key unmet needs for both patients (comfort) and physicians (efficiency and practice revenue).

Risk Factors

The company is pre-revenue and pre-launch, facing risks related to final regulatory clearance, clinical proof of superiority over existing techniques, and physician adoption in a conservative market.
Commercial success depends on overcoming the inertia associated with established, low-cost vasectomy methods.

Competitive Landscape

Competition includes traditional vasectomy techniques using scalpels, clips, and cautery, which are low-cost and well-established. Other medical device companies may offer specialized vasectomy kits, but Signati claims to be the first major innovation in decades, positioning its bipolar sealing technology as a potential differentiator in procedure speed and recovery.